4//SEC Filing
Kafka Steven J. 4
Accession 0001209191-17-064390
CIK 0001488613other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:03 PM ET
Size
9.0 KB
Accession
0001209191-17-064390
Insider Transaction Report
Form 4
Kafka Steven J.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2017-12-06$4.16/sh+5,774$24,020→ 96,761 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-06−5,774→ 50,896 totalExercise: $4.16Exp: 2023-03-07→ Common Stock (5,774 underlying) - Sale
Common Stock
2017-12-06$58.57/sh−5,774$338,183→ 90,987 total
Footnotes (2)
- [F1]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.25 to $58.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- [F2]This is an incentive stock option portion of an option granted on March 7, 2013 that vested in equal quarterly installments beginning on January 2, 2014 until fully vested on January 2, 2017.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeother
Related Parties
1- filerCIK 0001585005
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:03 PM ET
- Size
- 9.0 KB